SureScreen Digital Powered by TestCard app
A partnership developed between TestCard and SureScreen Diagnostics in collaboration with Guy’s and St Thomas’ NHS Foundation Trust (GSTT) that created a digital lateral flow reading and reporting solution.
Streamlining pathways, providing rapid test diagnostics
SureScreen Digital Powered by TestCard app provides real-time data to be evaluated and results passed to the Electronic Patient Record for optimal clinical intervention. The app doesn’t require direct access to EPR but can be instantly uploaded there through a one-way integration reducing transcription errors and administrative burden.
What is it?
The SureScreen Digital Powered by TestCard app uses the user’s phone camera as a clinical scanner, analysing the SureScreen lateral flow test and providing a clear yes or no result. The user is guided through an easy step-by-step guide making the app a simple way to access digital analysis. ClearScreen is intended for use in a clinical setting.
Benefits
The SureScreen Digital Powered by TestCard app removes subjectivity through digital analysis and provide reliable and accurate test results. This app also helps to saves administrative time, supports the end user in testing correctly, and maintains records for easy access and reporting.
SureScreen Digital Powered by TestCare features:
- Support for users to perform the test correctly
- Computer vision analysis with the suggested result
- Instant recording of test results and image of tests into a web portal
- Comprehensive record-keeping and reporting
- Integration of results into the Electronic Patient Record
Testimonials:
“Traditionally, lab testing can take up to 24 hours so a patient has to remain in isolation until then. But with the app and the Dual Flu & COVID test, we can carry out the test and get results in 10 minutes, and that’s a real game-changer.”
Dr Sam Douthwaite, Consultant in the virology dept & service lead for Infectious Diseases at Guy’s and St Thomas’.
“The digital reader has enabled improved patient flow and data assurance to help build resilience to support future long-term need.”
Dr Rahul Batra, Deputy Director, Centre for Clinical Infection & Diagnostics Research at Guy’s and St Thomas’.
“Lateral flow testing provided a result at the bedside within 10 mins which, when positive for symptomatic patients, enabled movement into a COVID-19 bay without delay.”
Dr Rahul Batra, Deputy Director, Centre for Clinical Infection & Diagnostics Research at Guy’s and St Thomas’.